COVID-19 mRNA booster vaccine induces transient CD8+T effector cell responses while conserving the memory pool for subsequent reactivation

Immunization with two mRNA vaccine doses elicits robust spike-specific CD8(+) T cell responses, but reports of waning immunity after COVID-19 vaccination prompt the introduction of booster vaccination campaigns. However, the effect of mRNA booster vaccination on the spike-specific CD8(+) T cell response remains unclear. Here we show that spike-specific CD8(+) T cells are activated and expanded in all analyzed individuals receiving the 3(rd) and 4(th) mRNA vaccine shots. This CD8(+) T cell boost response is followed by a contraction phase and lasts only for about 30-60 days. The spike-specific CD8(+) T memory stem cell pool is not affected by the 3(rd) vaccination. Both 4(th) vaccination and breakthrough infections with Delta and Omicron rapidly reactivate CD8(+) T memory cells. In contrast, neutralizing antibody responses display little boost effect towards Omicron. Thus, COVID-19 mRNA booster vaccination elicits a transient T effector cell response while long-term spike-specific CD8(+) T cell immunity is conserved to mount robust memory recall targeting emerging variants of concern. Vaccines induce beneficial immunity for COVID-19, but immune waning prompts boosting vaccination. Here, the authors show that a third, boosting dose of COVID-19 mRNA vaccine induces transient CD8 + T effector cell response while conserving the CD8 memory T cell pool, thereby permitting reactivation of spike-specific CD8 + T cells upon breakthrough infection or 4th vaccination.

Automated summary

The study demonstrates that COVID-19 mRNA booster vaccination induces a transient T effector cell response while preserving the CD8 memory T cell pool, allowing for reactivation of spike-specific CD8+ T cells during breakthrough infections or 4th vaccination.